Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Treasury Stock	Additional Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)
Balance at beginning of period (in shares) at Dec. 31, 2022		55,030,000
Balance at beginning of period at Dec. 31, 2022	$ 1,130,137	$ 55	$ (290,319)	$ 1,046,760	$ 390,728	$ (17,087)
Balance at beginning of period (in shares) at Dec. 31, 2022			(10,283,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(15,000)				(15,000)
Other comprehensive income (loss)	1,479					1,479
Share-based compensation	15,180			15,180
Issuance of common stock under employee stock plans (in shares)		322,000
Issuance of common stock under employee stock plans	12,114			12,114
Tax payments related to restricted stock units	(1,369)			(1,369)
Balance at end of period (in shares) at Mar. 31, 2023		55,352,000
Balance at end of period at Mar. 31, 2023	$ 1,142,541	$ 55	$ (290,319)	1,072,685	375,728	(15,608)
Balance at end of period (in shares) at Mar. 31, 2023			(10,283,000)
Balance at beginning of period (in shares) at Dec. 31, 2023	45,539,000	55,822,000
Balance at beginning of period at Dec. 31, 2023	$ 1,188,954	$ 56	$ (290,319)	1,122,292	370,357	(13,432)
Balance at beginning of period (in shares) at Dec. 31, 2023	(10,283,000)		(10,283,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	$ (15,676)				(15,676)
Other comprehensive income (loss)	(1,399)					(1,399)
Share-based compensation	9,381			9,381
Issuance of common stock under employee stock plans (in shares)		385,000
Issuance of common stock under employee stock plans	8,042			8,042
Tax payments related to restricted stock units	$ (705)			(705)
Balance at end of period (in shares) at Mar. 31, 2024	45,924,000	56,207,000
Balance at end of period at Mar. 31, 2024	$ 1,188,597	$ 56	$ (290,319)	$ 1,139,010	$ 354,681	$ (14,831)
Balance at end of period (in shares) at Mar. 31, 2024	(10,283,000)		(10,283,000)